Nanexa AB (NANEXA) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.040x

Based on the latest financial reports, Nanexa AB (NANEXA) has a cash flow conversion efficiency ratio of -0.040x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-5.14 Million ≈ $-553.15K USD) by net assets (Skr127.13 Million ≈ $13.68 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Nanexa AB (NANEXA) defensive interval to measure how many days the company can operate on defensive assets alone.

Nanexa AB - Cash Flow Conversion Efficiency Trend (2014–2025)

This chart illustrates how Nanexa AB's cash flow conversion efficiency has evolved over time, based on yearly financial data.

Nanexa AB Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Nanexa AB ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Superior Plating Technology Co Ltd TWO:8431	-0.024x
GIIR Inc KO:035000	0.007x
IBU tec advanced materials AG XETRA:IBU	0.255x
Global Data Centre Group AU:GDC	0.644x
PolyPid NASDAQ:PYPD	-2.876x
Globrands Group Ltd TA:GLRS	0.004x
Koryo Electronics Co Ltd TWO:8032	0.015x
Nasmedia Co. Ltd KQ:089600	-0.051x

Annual Cash Flow Conversion Efficiency for Nanexa AB (2014–2025)

The table below shows the annual cash flow conversion efficiency of Nanexa AB from 2014 to 2025. For the full company profile with market capitalisation and key ratios, see Nanexa AB (NANEXA) market capitalisation.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Skr101.53 Million ≈ $10.93 Million	Skr-1.46 Million ≈ $-157.33K	-0.014x	+96.14%
2024-12-31	Skr70.92 Million ≈ $7.63 Million	Skr-26.43 Million ≈ $-2.84 Million	-0.373x	+16.29%
2023-12-31	Skr95.83 Million ≈ $10.31 Million	Skr-42.66 Million ≈ $-4.59 Million	-0.445x	-516.99%
2022-12-31	Skr109.10 Million ≈ $11.74 Million	Skr-7.87 Million ≈ $-847.05K	-0.072x	+56.56%
2021-12-31	Skr151.29 Million ≈ $16.28 Million	Skr-25.13 Million ≈ $-2.70 Million	-0.166x	+57.21%
2020-12-31	Skr43.35 Million ≈ $4.67 Million	Skr-16.83 Million ≈ $-1.81 Million	-0.388x	-2.54%
2019-12-31	Skr24.88 Million ≈ $2.68 Million	Skr-9.42 Million ≈ $-1.01 Million	-0.379x	+8.75%
2018-12-31	Skr16.29 Million ≈ $1.75 Million	Skr-6.76 Million ≈ $-727.11K	-0.415x	-124.54%
2017-12-31	Skr27.46 Million ≈ $2.95 Million	Skr-5.07 Million ≈ $-545.87K	-0.185x	+51.07%
2016-12-31	Skr16.96 Million ≈ $1.83 Million	Skr-6.41 Million ≈ $-689.32K	-0.378x	+30.46%
2015-12-31	Skr6.07 Million ≈ $652.70K	Skr-3.29 Million ≈ $-354.41K	-0.543x	-241.43%
2014-12-31	Skr1.47 Million ≈ $158.09K	Skr563.99K ≈ $60.69K	0.384x	--

About Nanexa AB

ST:NANEXA Sweden Drug Manufacturers - Specialty & Generic

Market Cap

$77.75 Million

Skr722.52 Million SEK

Market Cap Rank

#20274 Global

#362 in Sweden

Share Price

Skr3.91

Change (1 day)

-8.00%

52-Week Range

Skr1.61 - Skr4.92

All Time High

Skr15.20